0001140361-21-001343 | S-4 | XBRL Viewer | Silver Spike Acquisition Corp

Document and Entity Information	9 Months Ended
Sep. 30, 2020
Cover [Abstract]
Entity Registrant Name	Silver Spike Acquisition Corp.
Entity Central Index Key	0001779474
Document Type	S-4
Amendment Flag	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false

BALANCE SHEET (FY) - USD ($)	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Jun. 06, 2019
Current assets
Cash	$ 623,644			$ 894,589
Prepaid expenses	89,125			257,110
Total Current Assets	712,769			1,151,699
Marketable securities held in Trust Account	254,115,791			251,924,993
Total Assets	254,828,560			253,076,692
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities - Accrued expenses	497,425			96,895
Deferred underwriting fee payable	8,750,000			8,750,000
Total Liabilities	9,247,425			8,846,895
Commitments
Class A ordinary shares subject to possible redemption, 23,740,181 shares at redemption value	240,581,127			239,229,796
Shareholders' Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0			0
Additional paid in capital	2,029,753			3,381,091
Retained earnings	2,969,497			1,618,159
Total Shareholders' Equity	5,000,008	$ 5,000,007	$ 5,000,004	5,000,001	$ 5,000,001	$ 20,000	$ 0
Total Liabilities and Shareholders' Equity	254,828,560			253,076,692
Class A Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares	133			126
Class B Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares	$ 625			$ 625

BALANCE SHEET (FY) (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
LIABILITIES AND SHAREHOLDERS' EQUITY
Ordinary shares subject to possible redemption (in shares)	23,668,455	23,740,181	23,750,733
Shareholders' Equity
Preference shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized (in shares)	1,000,000	1,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Class A Ordinary Shares [Member]
LIABILITIES AND SHAREHOLDERS' EQUITY
Ordinary shares subject to possible redemption (in shares)	23,668,455	23,740,181
Shareholders' Equity
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	200,000,000	200,000,000
Ordinary shares, shares issued (in shares)	1,331,545	1,259,819
Ordinary shares, shares outstanding (in shares)	1,331,545	1,259,819
Class B Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, shares issued (in shares)	6,250,000	6,250,000
Ordinary shares, shares outstanding (in shares)	6,250,000	6,250,000

STATEMENTS OF OPERATIONS (FY) - USD ($)

1 Months Ended

3 Months Ended

4 Months Ended

7 Months Ended

9 Months Ended

Jun. 30, 2019

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2019

Dec. 31, 2019

Sep. 30, 2020

STATEMENT OF OPERATIONS [Abstract]

Operating and formation costs

$ 159,017

$ 133,620

$ 138,620

$ 306,834

$ 839,460

Loss from operations

(159,017)

(133,620)

(138,620)

(306,834)

(839,460)

Other income:

Interest income

342,126

620,669

1,812,577

2,207,141

Unrealized gain on marketable securities held in Trust Account

(297,069)

66,074

112,416

(16,343)

Other income, net

45,057

686,743

1,924,993

2,190,798

Net (loss) income

$ (5,000)

$ (113,960)

$ (161,809)

$ 1,627,107

$ 553,123

$ 548,123

$ 1,618,159

$ 1,351,338

Weighted average shares outstanding, basic and diluted (in shares)

^[1]

7,566,134

6,910,082

6,792,210

7,111,079

7,538,169

Basic and diluted net loss per ordinary share (in dollars per share)

^[2]

$ (0.02)

$ (0.01)

$ (0.02)

$ (0.03)

$ (0.10)

[1]	Excludes an aggregate of 23,668,455 and 23,750,733 shares subject to possible redemption at September 30, 2020 and 2019, respectively.
[2]	Net loss per ordinary share - basic and diluted excludes income attributable to ordinary shares subject to possible redemption of $42,655 and $2,074,028 for the three and nine months ended September 30, 2020, respectively, and $652,406 for the three months ended September 30, 2019 and for the period from June 7, 2019 (inception) through September 30, 2019, respectively (see Note 2).

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (FY) - USD ($)	Ordinary Shares [Member] Class A [Member]	Ordinary Shares [Member] Class B [Member]	Additional Paid in Capital [Member]	Retained Earnings [Member]	Total	Class B [Member]
Beginning balance at Jun. 06, 2019	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Jun. 06, 2019	0	0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor	$ 0	$ 719	24,281	0	25,000
Issuance of Class B ordinary shares to Sponsor (in shares)	0	7,187,500
Net income	$ 0	$ 0	0	(5,000)	(5,000)
Ending balance at Jun. 30, 2019	$ 0	$ 719	24,281	(5,000)	20,000
Ending balance (in shares) at Jun. 30, 2019	0	7,187,500
Beginning balance at Jun. 06, 2019	$ 0	$ 0	0	0	0
Beginning balance (in shares) at Jun. 06, 2019	0	0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income					548,123
Ending balance at Sep. 30, 2019	$ 125	$ 625	4,451,128	548,123	5,000,001
Ending balance (in shares) at Sep. 30, 2019	1,249,267	6,250,000
Beginning balance at Jun. 06, 2019	$ 0	$ 0	0	0	0
Beginning balance (in shares) at Jun. 06, 2019	0	0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor	$ 0	$ 719	24,281	0	25,000
Issuance of Class B ordinary shares to Sponsor (in shares)	0	7,187,500
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses	$ 2,500	$ 0	235,584,138	0	235,586,638
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses (in shares)	25,000,000	0
Sale of 7,000,000 Private Placement Warrants	$ 0	$ 0	7,000,000	0	7,000,000
Forfeiture of 937,500 Class B ordinary shares	$ 0	$ (94)	94	0	0
Forfeiture of 937,500 Class B ordinary shares (in shares)	0	(937,500)				(937,500)
Ordinary shares subject to possible redemption	$ (2,374)	$ 0	(239,227,422)	0	(239,229,796)
Ordinary shares subject to possible redemption (in shares)	(23,740,181)	0
Net income	$ 0	$ 0	0	1,618,159	1,618,159
Ending balance at Dec. 31, 2019	$ 126	$ 625	3,381,091	1,618,159	5,000,001
Ending balance (in shares) at Dec. 31, 2019	1,259,819	6,250,000
Beginning balance at Jun. 30, 2019	$ 0	$ 719	24,281	(5,000)	20,000
Beginning balance (in shares) at Jun. 30, 2019	0	7,187,500
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses	$ 2,500	$ 0	235,584,138	0	235,586,638
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses (in shares)	25,000,000	0
Sale of 7,000,000 Private Placement Warrants	$ 0	$ 0	700,000	0	7,000,000
Forfeiture of 937,500 Class B ordinary shares	$ 0	$ (94)	94	0	0
Forfeiture of 937,500 Class B ordinary shares (in shares)	0	(937,500)				(937,500)
Ordinary shares subject to possible redemption	$ (2,375)	$ 0	(238,157,385)	0	(238,159,760)
Ordinary shares subject to possible redemption (in shares)	(23,750,733)	0
Net income	$ 0	$ 0	0	553,123	553,123
Ending balance at Sep. 30, 2019	$ 125	$ 625	4,451,128	548,123	5,000,001
Ending balance (in shares) at Sep. 30, 2019	1,249,267	6,250,000
Beginning balance at Dec. 31, 2019	$ 126	$ 625	3,381,091	1,618,159	5,000,001
Beginning balance (in shares) at Dec. 31, 2019	1,259,819	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income	$ 0	$ 0	0	1,627,107	1,627,107
Ending balance at Mar. 31, 2020	$ 129	$ 625	1,753,984	3,245,266	5,000,004
Ending balance (in shares) at Mar. 31, 2020	1,294,519	6,250,000
Beginning balance at Dec. 31, 2019	$ 126	$ 625	3,381,091	1,618,159	5,000,001
Beginning balance (in shares) at Dec. 31, 2019	1,259,819	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income					1,351,338
Ending balance at Sep. 30, 2020	$ 133	$ 625	2,029,753	2,969,497	5,000,008
Ending balance (in shares) at Sep. 30, 2020	1,331,545	6,250,000
Beginning balance at Mar. 31, 2020	$ 129	$ 625	1,753,984	3,245,266	5,000,004
Beginning balance (in shares) at Mar. 31, 2020	1,294,519	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income	$ 0	$ 0	0	(161,809)	(161,809)
Ending balance at Jun. 30, 2020	$ 132	$ 625	1,915,793	3,083,457	5,000,007
Ending balance (in shares) at Jun. 30, 2020	1,316,134	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income	$ 0	$ 0	0	(113,960)	(113,960)
Ending balance at Sep. 30, 2020	$ 133	$ 625	$ 2,029,753	$ 2,969,497	$ 5,000,008
Ending balance (in shares) at Sep. 30, 2020	1,331,545	6,250,000

STATEMENT OF CASH FLOWS (FY)	7 Months Ended
STATEMENT OF CASH FLOWS (FY)	Dec. 31, 2019 USD ($)
Cash Flows from Operating Activities:
Net income	$ 1,618,159
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(1,812,577)
Unrealized gain on marketable securities held in Trust Account	(112,416)
Changes in operating assets and liabilities:
Prepaid expenses	(257,110)
Accrued expenses	96,895
Net cash used in operating activities	(467,049)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(250,000,000)
Net cash used in investing activities	(250,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	245,000,000
Proceeds from sale of Private Placement Warrants	7,000,000
Proceeds from promissory note - related party	237,470
Repayment of promissory note - related party	(237,470)
Payment of offering costs	(638,362)
Net cash provided by financing activities	251,361,638
Net Change in Cash	894,589
Cash - Beginning	0
Cash - Ending	894,589
Non-Cash Investing and Financing Activities:
Initial classification of ordinary shares subject to possible redemption	237,606,630
Change in value of ordinary shares subject to possible redemption	1,623,166
Deferred underwriting fee	8,750,000
Offering costs paid directly by Sponsor from proceeds from issuance of ordinary shares	$ 25,000

CONDENSED BALANCE SHEETS (Unaudited) (Q3) - USD ($)	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Jun. 06, 2019
Current assets
Cash	$ 623,644			$ 894,589
Prepaid expenses	89,125			257,110
Total Current Assets	712,769			1,151,699
Marketable securities held in Trust Account	254,115,791			251,924,993
Total Assets	254,828,560			253,076,692
Current liabilities
Accounts payable and accrued expenses	497,425			96,895
Deferred underwriting fee payable	8,750,000			8,750,000
Total Liabilities	9,247,425			8,846,895
Commitments
Class A ordinary shares subject to possible redemption, 23,668,455 and 23,740,181 shares at redemption value at September 30, 2020 and December 31, 2019, respectively	240,581,127			239,229,796
Shareholders' Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0			0
Additional paid in capital	2,029,753			3,381,091
Retained earnings	2,969,497			1,618,159
Total Shareholders' Equity	5,000,008	$ 5,000,007	$ 5,000,004	5,000,001	$ 5,000,001	$ 20,000	$ 0
Total Liabilities and Shareholders' Equity	254,828,560			253,076,692
Class A Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares	133			126
Class B Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares	$ 625			$ 625

CONDENSED BALANCE SHEETS (Unaudited) (Q3) (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
LIABILITIES AND SHAREHOLDERS' EQUITY
Ordinary shares subject to possible redemption (in shares)	23,668,455	23,740,181	23,750,733
Shareholders' Equity
Preference shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized (in shares)	1,000,000	1,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Class A Ordinary Shares [Member]
LIABILITIES AND SHAREHOLDERS' EQUITY
Ordinary shares subject to possible redemption (in shares)	23,668,455	23,740,181
Shareholders' Equity
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	200,000,000	200,000,000
Ordinary shares, shares issued (in shares)	1,331,545	1,259,819
Ordinary shares, shares outstanding (in shares)	1,331,545	1,259,819
Class B Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, shares issued (in shares)	6,250,000	6,250,000
Ordinary shares, shares outstanding (in shares)	6,250,000	6,250,000

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (Q3) - USD ($)

1 Months Ended

3 Months Ended

4 Months Ended

7 Months Ended

9 Months Ended

Jun. 30, 2019

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2019

Dec. 31, 2019

Sep. 30, 2020

STATEMENT OF OPERATIONS [Abstract]

Formation and operating costs

$ 159,017

$ 133,620

$ 138,620

$ 306,834

$ 839,460

Loss from operations

(159,017)

(133,620)

(138,620)

(306,834)

(839,460)

Other income (expense):

Interest income on marketable securities held in Trust Account

342,126

620,669

1,812,577

2,207,141

Unrealized (loss) gain on marketable securities held in Trust Account

(297,069)

66,074

112,416

(16,343)

Other income, net

45,057

686,743

1,924,993

2,190,798

Net (loss) income

$ (5,000)

$ (113,960)

$ (161,809)

$ 1,627,107

$ 553,123

$ 548,123

$ 1,618,159

$ 1,351,338

Weighted average shares outstanding, basic and diluted (in shares)

^[1]

7,566,134

6,910,082

6,792,210

7,111,079

7,538,169

Basic and diluted net loss per ordinary share (in dollars per share)

^[2]

$ (0.02)

$ (0.01)

$ (0.02)

$ (0.03)

$ (0.10)

[1]	Excludes an aggregate of 23,668,455 and 23,750,733 shares subject to possible redemption at September 30, 2020 and 2019, respectively.
[2]	Net loss per ordinary share - basic and diluted excludes income attributable to ordinary shares subject to possible redemption of $42,655 and $2,074,028 for the three and nine months ended September 30, 2020, respectively, and $652,406 for the three months ended September 30, 2019 and for the period from June 7, 2019 (inception) through September 30, 2019, respectively (see Note 2).

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) (Q3) - USD ($)	Ordinary Shares [Member] Class A [Member]	Ordinary Shares [Member] Class B [Member]	Additional Paid in Capital [Member]	Retained Earnings [Member]	Total	Class B [Member]
Beginning balance at Jun. 06, 2019	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Jun. 06, 2019	0	0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor	$ 0	$ 719	24,281	0	25,000
Issuance of Class B ordinary shares to Sponsor (in shares)	0	7,187,500
Net (loss) income	$ 0	$ 0	0	(5,000)	(5,000)
Ending balance at Jun. 30, 2019	$ 0	$ 719	24,281	(5,000)	20,000
Ending balance (in shares) at Jun. 30, 2019	0	7,187,500
Beginning balance at Jun. 06, 2019	$ 0	$ 0	0	0	0
Beginning balance (in shares) at Jun. 06, 2019	0	0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net (loss) income					548,123
Ending balance at Sep. 30, 2019	$ 125	$ 625	4,451,128	548,123	5,000,001
Ending balance (in shares) at Sep. 30, 2019	1,249,267	6,250,000
Beginning balance at Jun. 06, 2019	$ 0	$ 0	0	0	0
Beginning balance (in shares) at Jun. 06, 2019	0	0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor	$ 0	$ 719	24,281	0	25,000
Issuance of Class B ordinary shares to Sponsor (in shares)	0	7,187,500
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses	$ 2,500	$ 0	235,584,138	0	235,586,638
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses (in shares)	25,000,000	0
Sale of 7,000,000 Private Placement Warrants	$ 0	$ 0	7,000,000	0	7,000,000
Forfeiture of 937,500 Class B ordinary shares	$ 0	$ (94)	94	0	0
Forfeiture of 937,500 Class B ordinary shares (in shares)	0	(937,500)				(937,500)
Ordinary shares subject to possible redemption	$ (2,374)	$ 0	(239,227,422)	0	(239,229,796)
Ordinary shares subject to possible redemption (in shares)	(23,740,181)	0
Net (loss) income	$ 0	$ 0	0	1,618,159	1,618,159
Ending balance at Dec. 31, 2019	$ 126	$ 625	3,381,091	1,618,159	5,000,001
Ending balance (in shares) at Dec. 31, 2019	1,259,819	6,250,000
Beginning balance at Jun. 30, 2019	$ 0	$ 719	24,281	(5,000)	20,000
Beginning balance (in shares) at Jun. 30, 2019	0	7,187,500
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses	$ 2,500	$ 0	235,584,138	0	235,586,638
Sale of 25,000,000 Units, net of underwriting discounts and offering expenses (in shares)	25,000,000	0
Sale of 7,000,000 Private Placement Warrants	$ 0	$ 0	700,000	0	7,000,000
Forfeiture of 937,500 Class B ordinary shares	$ 0	$ (94)	94	0	0
Forfeiture of 937,500 Class B ordinary shares (in shares)	0	(937,500)				(937,500)
Ordinary shares subject to possible redemption	$ (2,375)	$ 0	(238,157,385)	0	(238,159,760)
Ordinary shares subject to possible redemption (in shares)	(23,750,733)	0
Net (loss) income	$ 0	$ 0	0	553,123	553,123
Ending balance at Sep. 30, 2019	$ 125	$ 625	4,451,128	548,123	5,000,001
Ending balance (in shares) at Sep. 30, 2019	1,249,267	6,250,000
Beginning balance at Dec. 31, 2019	$ 126	$ 625	3,381,091	1,618,159	5,000,001
Beginning balance (in shares) at Dec. 31, 2019	1,259,819	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Change in value of ordinary shares subject to possible redemption	$ 3	$ 0	(1,627,107)	0	(1,627,104)
Change in value of ordinary shares subject to possible redemption (in shares)	34,700	0
Net (loss) income	$ 0	$ 0	0	1,627,107	1,627,107
Ending balance at Mar. 31, 2020	$ 129	$ 625	1,753,984	3,245,266	5,000,004
Ending balance (in shares) at Mar. 31, 2020	1,294,519	6,250,000
Beginning balance at Dec. 31, 2019	$ 126	$ 625	3,381,091	1,618,159	5,000,001
Beginning balance (in shares) at Dec. 31, 2019	1,259,819	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net (loss) income					1,351,338
Ending balance at Sep. 30, 2020	$ 133	$ 625	2,029,753	2,969,497	5,000,008
Ending balance (in shares) at Sep. 30, 2020	1,331,545	6,250,000
Beginning balance at Mar. 31, 2020	$ 129	$ 625	1,753,984	3,245,266	5,000,004
Beginning balance (in shares) at Mar. 31, 2020	1,294,519	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Change in value of ordinary shares subject to possible redemption	$ 3	$ 0	161,809	0	161,812
Change in value of ordinary shares subject to possible redemption (in shares)	21,615	0
Net (loss) income	$ 0	$ 0	0	(161,809)	(161,809)
Ending balance at Jun. 30, 2020	$ 132	$ 625	1,915,793	3,083,457	5,000,007
Ending balance (in shares) at Jun. 30, 2020	1,316,134	6,250,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Change in value of ordinary shares subject to possible redemption	$ 1	$ 0	113,960	0	113,961
Change in value of ordinary shares subject to possible redemption (in shares)	15,411	0
Net (loss) income	$ 0	$ 0	0	(113,960)	(113,960)
Ending balance at Sep. 30, 2020	$ 133	$ 625	$ 2,029,753	$ 2,969,497	$ 5,000,008
Ending balance (in shares) at Sep. 30, 2020	1,331,545	6,250,000

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (Q3) - USD ($)	4 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2020
Cash Flows from Operating Activities:
Net income	$ 548,123	$ 1,351,338
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(620,669)	(2,207,141)
Unrealized loss (gain) on marketable securities held in Trust Account	(66,074)	16,343
Changes in operating assets and liabilities:
Prepaid expenses	(312,137)	167,985
Accounts payable and accrued expenses	76,397	400,530
Net cash used in operating activities	(374,360)	(270,945)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(250,000,000)	0
Net cash used in investing activities	(250,000,000)	0
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	245,000,000	0
Proceeds from sale of Private Placement Warrants	7,000,000	0
Proceeds from promissory note - related party	237,470	0
Repayment of promissory note - related party	(237,470)	0
Payment of offering costs	(638,362)	0
Net cash provided by financing activities	251,361,638	0
Net Change in Cash	987,278	(270,945)
Cash - Beginning	0	894,589
Cash - Ending	987,278	623,644
Non-Cash Investing and Financing Activities:
Initial classification of ordinary shares subject to possible redemption	237,606,630	0
Change in value of ordinary shares subject to possible redemption	553,130	1,351,331
Deferred underwriting fee	8,750,000	0
Deferred offering costs paid directly by Sponsor in exchange for the issuance of ordinary shares	$ 25,000	$ 0

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (FY)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Silver Spike Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 7, 2019. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate and, in particular, the Company will not invest in, or consummate a Business Combination with, a target business that the Company determines has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2020, the Company had not commenced any operations. All activity through September 30, 2020 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on August 7, 2019. On August 12, 2019, the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”) at $10.00 per unit, generating gross proceeds of $250,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Silver Spike Sponsor, LLC (the “Sponsor”), generating gross proceeds of $7,000,000, which is described in Note 4. Transaction costs amounted to $14,413,362, consisting of $5,000,000 of underwriting fees, $8,750,000 of deferred underwriting fees and $663,362 of other offering costs. In addition, as of September 30, 2020, cash of $623,644 was held outside of the Trust and is available for working capital purposes. Following the closing of the Initial Public Offering on August 12, 2019, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of the Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share) as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets, after payment of the deferred underwriting commission, of at least $5,000,001 upon such completion of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination or seek to sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, subject to the immediately succeeding paragraph, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to 15% or more of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination (and not seek to sell its shares to the Company in any tender offer the Company undertakes in connection with its initial Business Combination) and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Public Offering or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (c) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have until February 12, 2021 (the “Combination Period”) to consummate a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Silver Spike Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 7, 2019. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate and, in particular, the Company will not invest in, or consummate a Business Combination with, a target business that the Company determines has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2019, the Company had not commenced any operations. All activity for the period from June 7, 2019 (inception) through December 31, 2019 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on August 7, 2019. On August 12, 2019, the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”) at $10.00 per unit, generating gross proceeds of $250,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Silver Spike Sponsor, LLC (the “Sponsor”), generating gross proceeds of $7,000,000, which is described in Note 4. Transaction costs amounted to $14,413,362, consisting of $5,000,000 of underwriting fees, $8,750,000 of deferred underwriting fees and $663,362 of other offering costs. In addition, as of December 31, 2019, cash of $894,589 was held outside of the Trust and is available for working capital purposes. Following the closing of the Initial Public Offering on August 12, 2019, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of the Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share) as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets, after payment of the deferred underwriting commission, of at least $5,000,001 upon such completion of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination or seek to sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, subject to the immediately succeeding paragraph, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to 15% or more of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination (and not seek to sell its shares to the Company in any tender offer the Company undertakes in connection with its initial Business Combination) and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Public Offering or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (c) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have until February 12, 2021 (the “Combination Period”) to consummate a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (FY)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the SEC on March 30, 2020, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2019 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The interim results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2020 and December 31, 2019.

Marketable Securities Held in Trust Account

At September 30, 2020 and December 31, 2019, the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Loss Per Ordinary Share

Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at September 30, 2020, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 19,500,000 ordinary shares in the calculation of diluted loss per share, since the exercise of the warrants into ordinary shares is contingent upon the occurrence of future events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented.

Reconciliation of Net Loss Per Ordinary Share

The Company’s net (loss) income is adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per ordinary share is calculated as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,			For the Period from June 7, 2019 (Inception) Through September 30,
	2020			2019			2020			2019
Net (loss) income	$	(113,960	)	$	553,123		$	1,351,338		$	548,123
Less: Income attributable to ordinary shares subject to possible redemption		(42,655	)		(652,406	)		(2,074,028	)		(652,406	)
Adjusted net loss	$	(156,615	)	$	(99,283	)	$	(722,690	)	$	(104,283	)

Weighted average shares outstanding, basic and diluted		7,566,134			6,910,082			7,538,169			6,792,210

Basic and diluted net loss per ordinary share	$	(0.02	)	$	(0.01	)	$	(0.10	)	$	(0.02	)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed financial statements, primarily due to their short-term nature.

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the condensed financial statements.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

Emerging growth company

Use of estimates

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

Cash and cash equivalents

Marketable securities held in Trust Account

At December 31, 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills.

Class A ordinary shares subject to possible redemption

Net loss per ordinary share

Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at December 31, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 19,500,000 ordinary shares in the calculation of diluted loss per share, since the exercise of the warrants into ordinary shares is contingent upon the occurrence of future events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented.

Reconciliation of net loss per ordinary share

The Company’s net income is adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per ordinary share is calculated as follows:

	For the Period from June 7, 2019 (inception) through December 31, 2019
Net income	$	1,618,159
Less: Income attributable to ordinary shares subject to possible redemption		(1,827,973	)
Adjusted net loss	$	(209,814	)
Weighted average shares outstanding, basic and diluted		7,111,079
Basic and diluted net loss per ordinary share	$	(0.03	)

Income taxes

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Concentration of credit risk

Fair value of financial instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying financial statements, primarily due to their short-term nature.

Recently issued accounting standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements.

RELATED PARTY TRANSACTIONS (FY)	9 Months Ended	12 Months Ended
RELATED PARTY TRANSACTIONS (FY)	Sep. 30, 2020	Dec. 31, 2019
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In June 2019, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination on a one-for-one basis, subject to certain adjustments, as described in Note 7. The Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. The underwriters’ over-allotment option expired unexercised on September 26, 2019 and, as a result, 937,500 Founder Shares were forfeited, resulting in the Sponsor holding an aggregate of 6,250,000 Founder Shares. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Promissory Note – Related Party On June 10, 2019, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company borrowed an aggregate principal amount of $237,470. The note was non-interest bearing and payable on the earlier of (i) January 31, 2020 and (ii) the completion of the Initial Public Offering. The note was repaid in full upon the consummation of the Initial Public Offering on August 12, 2019. Administrative Services Agreement The Company entered into an agreement whereby, commencing on August 7, 2019, the Company will pay the Sponsor up to $20,000 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2020, the Company incurred $60,000 and $180,000, respectively, in fees for these services. At September 30, 2020 and December 31, 2019, fees of $219,879 and $82,228, respectively, are included in accrued expenses in the accompanying condensed balance sheets. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In June 2019, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination on a one-for-one basis, subject to certain adjustments, as described in Note 7. The Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. The underwriters’ over-allotment option expired unexercised on September 26, 2019 and, as a result, 937,500 Founder Shares were forfeited, resulting in the Sponsor holding an aggregate of 6,250,000 Founder Shares. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Promissory Note – Related Party On June 10, 2019, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company borrowed an aggregate principal amount of $237,470. The note was non-interest bearing and payable on the earlier of (i) January 31, 2020 and (ii) the completion of the Initial Public Offering. The note was repaid in full upon the consummation of the Initial Public Offering on August 12, 2019. Administrative Services Agreement The Company entered into an agreement whereby, commencing on August 7, 2019, the Company will pay the Sponsor up to $20,000 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the period from June 7, 2019 (inception) through December 31, 2019, the Company incurred $92,903 in fees for these services, of which $82,228 of such fees are included in accrued expenses in the accompanying balance sheet. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

SHAREHOLDERS' EQUITY (FY)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

SHAREHOLDERS' EQUITY [Abstract]

SHAREHOLDERS' EQUITY

NOTE 7. SHAREHOLDERS’ EQUITY

Preferred Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. At September 30, 2020 and December 31, 2019, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue 200,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At September 30, 2020 and December 31, 2019, there were 1,331,545 and 1,259,819 shares of Class A ordinary shares issued or outstanding, excluding 23,668,455 and 23,740,181 Class A ordinary shares subject to possible redemption, respectively.

Class B Ordinary Shares — The Company is authorized to issue 20,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At September 30, 2020 and December 31, 2019, there were 6,250,000 Class B ordinary shares issued and outstanding.

Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise required by law.

The Class B Shares will automatically convert into Class A ordinary shares on the first business day following the completion of the Business Combination, on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Founder Shares will convert into Class A ordinary shares will be adjusted (subject to waiver by holders of a majority of the Class B ordinary shares) so that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the ordinary shares issued and outstanding upon completion of the Initial Public Offering plus the number of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with a Business Combination (net of redemptions), excluding any Class A ordinary shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor.

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its reasonable best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use it’s reasonable best efforts to cause the same to become effective within 60 business days after the closing of the Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a Public Warrant, not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its reasonable best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption:

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the notice of redemption to the warrant holders.

If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “newly issued price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the newly issued price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the newly issued price.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

NOTE 7. SHAREHOLDERS’ EQUITY

Preferred Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. At December 31, 2019, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue 200,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At December 31, 2019, there were 1,259,819 shares of Class A ordinary shares issued or outstanding, excluding 23,740,181 Class A ordinary shares subject to possible redemption.

Class B Ordinary Shares — The Company is authorized to issue 20,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At December 31, 2019, there were 6,250,000 Class B ordinary shares issued and outstanding.

The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its reasonable best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use it reasonable best efforts to cause the same to become effective within 60 business days after the closing of the Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a Public Warrant, not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its reasonable best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption:

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

FAIR VALUE MEASUREMENTS (FY)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

FAIR VALUE MEASUREMENTS [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

•

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

•

Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

•

Level 3: Unobservable inputs based on the Company assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2020 and December 31, 2019, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description	Level		September 30, 2020		December 31, 2019
Assets:
Marketable securities held in Trust Account		1	$	254,115,791	$	251,924,993

NOTE 8. FAIR VALUE MEASUREMENTS

•

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2019, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description	Level		December 31, 2019
Assets:
Marketable securities held in Trust Account		1	$	251,924,993

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Q3)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Silver Spike Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 7, 2019. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate and, in particular, the Company will not invest in, or consummate a Business Combination with, a target business that the Company determines has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2020, the Company had not commenced any operations. All activity through September 30, 2020 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on August 7, 2019. On August 12, 2019, the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”) at $10.00 per unit, generating gross proceeds of $250,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Silver Spike Sponsor, LLC (the “Sponsor”), generating gross proceeds of $7,000,000, which is described in Note 4. Transaction costs amounted to $14,413,362, consisting of $5,000,000 of underwriting fees, $8,750,000 of deferred underwriting fees and $663,362 of other offering costs. In addition, as of September 30, 2020, cash of $623,644 was held outside of the Trust and is available for working capital purposes. Following the closing of the Initial Public Offering on August 12, 2019, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of the Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share) as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets, after payment of the deferred underwriting commission, of at least $5,000,001 upon such completion of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination or seek to sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, subject to the immediately succeeding paragraph, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to 15% or more of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination (and not seek to sell its shares to the Company in any tender offer the Company undertakes in connection with its initial Business Combination) and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Public Offering or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (c) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have until February 12, 2021 (the “Combination Period”) to consummate a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Silver Spike Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 7, 2019. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate and, in particular, the Company will not invest in, or consummate a Business Combination with, a target business that the Company determines has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2019, the Company had not commenced any operations. All activity for the period from June 7, 2019 (inception) through December 31, 2019 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on August 7, 2019. On August 12, 2019, the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”) at $10.00 per unit, generating gross proceeds of $250,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Silver Spike Sponsor, LLC (the “Sponsor”), generating gross proceeds of $7,000,000, which is described in Note 4. Transaction costs amounted to $14,413,362, consisting of $5,000,000 of underwriting fees, $8,750,000 of deferred underwriting fees and $663,362 of other offering costs. In addition, as of December 31, 2019, cash of $894,589 was held outside of the Trust and is available for working capital purposes. Following the closing of the Initial Public Offering on August 12, 2019, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of the Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share) as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets, after payment of the deferred underwriting commission, of at least $5,000,001 upon such completion of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination or seek to sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, subject to the immediately succeeding paragraph, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to 15% or more of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination (and not seek to sell its shares to the Company in any tender offer the Company undertakes in connection with its initial Business Combination) and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Public Offering or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (c) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have until February 12, 2021 (the “Combination Period”) to consummate a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Q3)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Marketable Securities Held in Trust Account

At September 30, 2020 and December 31, 2019, the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills.

Class A Ordinary Shares Subject to Possible Redemption

Income Taxes

Net Loss Per Ordinary Share

Reconciliation of Net Loss Per Ordinary Share

	Three Months Ended September 30,						Nine Months Ended September 30,			For the Period from June 7, 2019 (Inception) Through September 30,
	2020			2019			2020			2019
Net (loss) income	$	(113,960	)	$	553,123		$	1,351,338		$	548,123
Less: Income attributable to ordinary shares subject to possible redemption		(42,655	)		(652,406	)		(2,074,028	)		(652,406	)
Adjusted net loss	$	(156,615	)	$	(99,283	)	$	(722,690	)	$	(104,283	)

Weighted average shares outstanding, basic and diluted		7,566,134			6,910,082			7,538,169			6,792,210

Basic and diluted net loss per ordinary share	$	(0.02	)	$	(0.01	)	$	(0.10	)	$	(0.02	)

Concentration of Credit Risk

Fair Value of Financial Instruments

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the condensed financial statements.

Risks and Uncertainties

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

Emerging growth company

Use of estimates

Cash and cash equivalents

Marketable securities held in Trust Account

At December 31, 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills.

Class A ordinary shares subject to possible redemption

Net loss per ordinary share

Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at December 31, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 19,500,000 ordinary shares in the calculation of diluted loss per share, since the exercise of the warrants into ordinary shares is contingent upon the occurrence of future events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented.

Reconciliation of net loss per ordinary share

	For the Period from June 7, 2019 (inception) through December 31, 2019
Net income	$	1,618,159
Less: Income attributable to ordinary shares subject to possible redemption		(1,827,973	)
Adjusted net loss	$	(209,814	)
Weighted average shares outstanding, basic and diluted		7,111,079
Basic and diluted net loss per ordinary share	$	(0.03	)

Income taxes

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Concentration of credit risk

Fair value of financial instruments

Recently issued accounting standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements.

RELATED PARTY TRANSACTIONS (Q3)	9 Months Ended	12 Months Ended
RELATED PARTY TRANSACTIONS (Q3)	Sep. 30, 2020	Dec. 31, 2019
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In June 2019, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination on a one-for-one basis, subject to certain adjustments, as described in Note 7. The Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. The underwriters’ over-allotment option expired unexercised on September 26, 2019 and, as a result, 937,500 Founder Shares were forfeited, resulting in the Sponsor holding an aggregate of 6,250,000 Founder Shares. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Promissory Note – Related Party On June 10, 2019, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company borrowed an aggregate principal amount of $237,470. The note was non-interest bearing and payable on the earlier of (i) January 31, 2020 and (ii) the completion of the Initial Public Offering. The note was repaid in full upon the consummation of the Initial Public Offering on August 12, 2019. Administrative Services Agreement The Company entered into an agreement whereby, commencing on August 7, 2019, the Company will pay the Sponsor up to $20,000 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2020, the Company incurred $60,000 and $180,000, respectively, in fees for these services. At September 30, 2020 and December 31, 2019, fees of $219,879 and $82,228, respectively, are included in accrued expenses in the accompanying condensed balance sheets. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In June 2019, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination on a one-for-one basis, subject to certain adjustments, as described in Note 7. The Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. The underwriters’ over-allotment option expired unexercised on September 26, 2019 and, as a result, 937,500 Founder Shares were forfeited, resulting in the Sponsor holding an aggregate of 6,250,000 Founder Shares. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Promissory Note – Related Party On June 10, 2019, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company borrowed an aggregate principal amount of $237,470. The note was non-interest bearing and payable on the earlier of (i) January 31, 2020 and (ii) the completion of the Initial Public Offering. The note was repaid in full upon the consummation of the Initial Public Offering on August 12, 2019. Administrative Services Agreement The Company entered into an agreement whereby, commencing on August 7, 2019, the Company will pay the Sponsor up to $20,000 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the period from June 7, 2019 (inception) through December 31, 2019, the Company incurred $92,903 in fees for these services, of which $82,228 of such fees are included in accrued expenses in the accompanying balance sheet. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

SHAREHOLDERS' EQUITY (Q3)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

SHAREHOLDERS' EQUITY [Abstract]

SHAREHOLDERS' EQUITY

NOTE 7. SHAREHOLDERS’ EQUITY

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption:

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

NOTE 7. SHAREHOLDERS’ EQUITY

Preferred Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. At December 31, 2019, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue 200,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At December 31, 2019, there were 1,259,819 shares of Class A ordinary shares issued or outstanding, excluding 23,740,181 Class A ordinary shares subject to possible redemption.

Class B Ordinary Shares — The Company is authorized to issue 20,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At December 31, 2019, there were 6,250,000 Class B ordinary shares issued and outstanding.

The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its reasonable best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use it reasonable best efforts to cause the same to become effective within 60 business days after the closing of the Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a Public Warrant, not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its reasonable best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption:

•

in whole and not in part;

•

at a price of $0.01 per Public Warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

FAIR VALUE MEASUREMENTS (Q3)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

FAIR VALUE MEASUREMENTS [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

•

Level 3: Unobservable inputs based on the Company assessment of the assumptions that market participants would use in pricing the asset or liability.

Description	Level		September 30, 2020		December 31, 2019
Assets:
Marketable securities held in Trust Account		1	$	254,115,791	$	251,924,993

NOTE 8. FAIR VALUE MEASUREMENTS

•

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

Description	Level		December 31, 2019
Assets:
Marketable securities held in Trust Account		1	$	251,924,993

- Definition

+ References + Details

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (FY) (Policies)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Basis of Presentation

Basis of presentation

Use of Estimates

Use of estimates

Cash and Cash Equivalents

Cash and cash equivalents

Marketable Securities Held in Trust Account

At September 30, 2020 and December 31, 2019, the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills.

Marketable securities held in Trust Account

At December 31, 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills.

Class A Ordinary Shares Subject to Possible Redemption

Class A ordinary shares subject to possible redemption

Net Loss Per Ordinary Share

Reconciliation of Net Loss Per Ordinary Share

	Three Months Ended September 30,						Nine Months Ended September 30,			For the Period from June 7, 2019 (Inception) Through September 30,
	2020			2019			2020			2019
Net (loss) income	$	(113,960	)	$	553,123		$	1,351,338		$	548,123
Less: Income attributable to ordinary shares subject to possible redemption		(42,655	)		(652,406	)		(2,074,028	)		(652,406	)
Adjusted net loss	$	(156,615	)	$	(99,283	)	$	(722,690	)	$	(104,283	)

Weighted average shares outstanding, basic and diluted		7,566,134			6,910,082			7,538,169			6,792,210

Basic and diluted net loss per ordinary share	$	(0.02	)	$	(0.01	)	$	(0.10	)	$	(0.02	)

Net loss per ordinary share

Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at December 31, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 19,500,000 ordinary shares in the calculation of diluted loss per share, since the exercise of the warrants into ordinary shares is contingent upon the occurrence of future events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented.

Reconciliation of net loss per ordinary share

	For the Period from June 7, 2019 (inception) through December 31, 2019
Net income	$	1,618,159
Less: Income attributable to ordinary shares subject to possible redemption		(1,827,973	)
Adjusted net loss	$	(209,814	)
Weighted average shares outstanding, basic and diluted		7,111,079
Basic and diluted net loss per ordinary share	$	(0.03	)

Income Taxes

Income taxes

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Concentration of Credit Risk

Concentration of credit risk

Fair Value of Financial Instruments

Fair value of financial instruments

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the condensed financial statements.

Recently issued accounting standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Q3) (Policies)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Basis of Presentation

Basis of presentation

Use of Estimates

Use of estimates

Cash and Cash Equivalents

Cash and cash equivalents

Marketable Securities Held in Trust Account

At September 30, 2020 and December 31, 2019, the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills.

Marketable securities held in Trust Account

At December 31, 2019, the assets held in the Trust Account were substantially held in U.S. Treasury Bills.

Class A Ordinary Shares Subject to Possible Redemption

Class A ordinary shares subject to possible redemption

Income Taxes

Income taxes

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Net Loss Per Ordinary Share

Reconciliation of Net Loss Per Ordinary Share

	Three Months Ended September 30,						Nine Months Ended September 30,			For the Period from June 7, 2019 (Inception) Through September 30,
	2020			2019			2020			2019
Net (loss) income	$	(113,960	)	$	553,123		$	1,351,338		$	548,123
Less: Income attributable to ordinary shares subject to possible redemption		(42,655	)		(652,406	)		(2,074,028	)		(652,406	)
Adjusted net loss	$	(156,615	)	$	(99,283	)	$	(722,690	)	$	(104,283	)

Weighted average shares outstanding, basic and diluted		7,566,134			6,910,082			7,538,169			6,792,210

Basic and diluted net loss per ordinary share	$	(0.02	)	$	(0.01	)	$	(0.10	)	$	(0.02	)

Net loss per ordinary share

Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at December 31, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 19,500,000 ordinary shares in the calculation of diluted loss per share, since the exercise of the warrants into ordinary shares is contingent upon the occurrence of future events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented.

Reconciliation of net loss per ordinary share

	For the Period from June 7, 2019 (inception) through December 31, 2019
Net income	$	1,618,159
Less: Income attributable to ordinary shares subject to possible redemption		(1,827,973	)
Adjusted net loss	$	(209,814	)
Weighted average shares outstanding, basic and diluted		7,111,079
Basic and diluted net loss per ordinary share	$	(0.03	)

Concentration of Credit Risk

Concentration of credit risk

Fair Value of Financial Instruments

Fair value of financial instruments

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the condensed financial statements.

Recently issued accounting standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements.

Risks and Uncertainties

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (FY) (Details) - USD ($)		3 Months Ended	4 Months Ended	7 Months Ended	9 Months Ended
	Aug. 12, 2019	Sep. 30, 2019	Sep. 30, 2019	Dec. 31, 2019	Sep. 30, 2020
Proceeds from Issuance of Equity [Abstract]
Share price (in dollars per share)	$ 1.00
Gross proceeds from initial public offering			$ 245,000,000		$ 0
Warrants issued (in shares)	7,000,000
Gross proceeds from issuance of warrants	$ 7,000,000
Transaction costs				$ 14,413,362
Underwriting fees	5,000,000			5,000,000
Deferred underwriting fees	8,750,000			8,750,000
Other offering costs	663,362			663,362
Cash				894,589	623,644
Investment of cash in Trust Account	$ 250,000,000		$ 250,000,000	250,000,000	0
Amount of interest to pay dissolution expenses				$ 100,000	$ 100,000
Private Placement Warrants [Member]
Proceeds from Issuance of Equity [Abstract]
Share price (in dollars per share)	$ 1.00
Warrants issued (in shares)	7,000,000	7,000,000		7,000,000
Gross proceeds from issuance of warrants	$ 7,000,000
Initial Public Offering [Member]
Proceeds from Issuance of Equity [Abstract]
Units issued (in shares)	25,000,000			25,000,000
Share price (in dollars per share)	$ 10.00			$ 10.00
Gross proceeds from initial public offering	$ 250,000,000
Redemption price (in dollars per share)	$ 10.00

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Loss Per Ordinary Share (FY) (Details) - USD ($)

1 Months Ended

3 Months Ended

4 Months Ended

7 Months Ended

9 Months Ended

Jun. 30, 2019

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2019

Dec. 31, 2019

Sep. 30, 2020

Cash and Cash Equivalents [Abstract]

Cash equivalents

$ 0

Reconciliation of Net Loss per Ordinary Share [Abstract]

Net income

$ (5,000)

(113,960)

$ (161,809)

$ 1,627,107

$ 553,123

$ 548,123

1,618,159

1,351,338

Less: Income attributable to ordinary shares subject to possible redemption

(42,655)

(652,406)

(1,827,973)

(2,074,028)

Adjusted net loss

$ (156,615)

$ (99,283)

$ (104,283)

$ (209,814)

$ (722,690)

Weighted average shares outstanding, basic and diluted (in shares)

^[1]

7,566,134

6,910,082

6,792,210

7,111,079

7,538,169

Basic and diluted net loss per ordinary share (in dollars per share)

^[2]

$ (0.02)

$ (0.01)

$ (0.02)

$ (0.03)

$ (0.10)

Class A Ordinary Shares [Member]

Net Loss per Ordinary Share [Abstract]

Shares excluded in calculation of diluted loss per share (in shares)

19,500,000

[1]	Excludes an aggregate of 23,668,455 and 23,750,733 shares subject to possible redemption at September 30, 2020 and 2019, respectively.
[2]	Net loss per ordinary share - basic and diluted excludes income attributable to ordinary shares subject to possible redemption of $42,655 and $2,074,028 for the three and nine months ended September 30, 2020, respectively, and $652,406 for the three months ended September 30, 2019 and for the period from June 7, 2019 (inception) through September 30, 2019, respectively (see Note 2).

RELATED PARTY TRANSACTIONS, Founder Shares (FY) (Details)		1 Months Ended	3 Months Ended	7 Months Ended	9 Months Ended
	Sep. 26, 2019 shares	Jun. 30, 2019 USD ($) shares	Sep. 30, 2019 shares	Dec. 31, 2019 USD ($) $ / shares shares	Sep. 30, 2020 $ / shares shares
Founder Shares [Abstract]
Proceeds from issuance of common stock to Sponsor \| $				$ 245,000,000
Number of trading days				20 days	20 days
Trading day threshold period				30 days	30 days
Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Number of shares outstanding (in shares)				1,259,819	1,331,545
Share price threshold to transfer, assign or sell shares (in dollars per share) \| $ / shares				$ 18.00	$ 18.00
Class A Ordinary Shares [Member] \| Minimum [Member]
Founder Shares [Abstract]
Share price threshold to transfer, assign or sell shares (in dollars per share) \| $ / shares				$ 12.00	$ 12.00
Threshold period after initial business combination				150 days	150 days
Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Forfeiture of ordinary shares (in shares)			937,500	937,500
Number of shares outstanding (in shares)				6,250,000	6,250,000
Sponsor [Member] \| Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Number of trading days				20 days	20 days
Trading day threshold period				30 days	30 days
Sponsor [Member] \| Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Shares issued (in shares)		7,187,500
Proceeds from issuance of common stock to Sponsor \| $		$ 25,000
Stock conversion ratio		1
Percentage of shares held by Founder after Initial Public Offering		20.00%		20.00%
Forfeiture of ordinary shares (in shares)	937,500
Number of shares outstanding (in shares)				6,250,000	6,250,000
Sponsor [Member] \| Class B Ordinary Shares [Member] \| Maximum [Member]
Founder Shares [Abstract]
Number of shares subject to forfeiture (in shares)			937,500	937,500

SHAREHOLDERS' EQUITY, Ordinary Shares (FY) (Details)	7 Months Ended	9 Months Ended
SHAREHOLDERS' EQUITY, Ordinary Shares (FY) (Details)	Dec. 31, 2019 Vote $ / shares shares	Sep. 30, 2020 Vote $ / shares shares	Sep. 30, 2019 shares
Stockholders' Equity [Abstract]
Ordinary shares subject to possible redemption (in shares)	23,740,181	23,668,455	23,750,733
Conversion of stock at the time of an initial business combination (in shares)	1	1
Stock conversion percentage threshold	20.00%	20.00%
Class A Ordinary Shares [Member]
Stockholders' Equity [Abstract]
Ordinary shares, shares authorized (in shares)	200,000,000	200,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Votes per share \| Vote	1	1
Ordinary shares, shares issued (in shares)	1,259,819	1,331,545
Ordinary shares, shares outstanding (in shares)	1,259,819	1,331,545
Ordinary shares subject to possible redemption (in shares)	23,740,181	23,668,455
Class B Ordinary Shares [Member]
Stockholders' Equity [Abstract]
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Votes per share \| Vote	1	1
Ordinary shares, shares issued (in shares)	6,250,000	6,250,000
Ordinary shares, shares outstanding (in shares)	6,250,000	6,250,000

SHAREHOLDERS' EQUITY, Warrants (FY) (Details) - $ / shares	7 Months Ended	9 Months Ended
	Dec. 31, 2019	Sep. 30, 2020
Warrants [Abstract]
Period to exercise warrants after business combination	30 days	30 days
Period to exercise warrants after public offerings	12 months	12 months
Expiration period of warrants	5 years	5 years
Number of days to file registration statement	15 days	15 days
Period for registration statement to become effective	60 days	60 days
Warrant redemption price (in dollars per share)	$ 0.01	$ 0.01
Notice period to redeem warrants	30 days	30 days
Number of trading days	20 days	20 days
Trading day threshold period	30 days	30 days
Limitation period to transfer, assign or sell warrants	30 days	30 days
Class A Ordinary Shares [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 18.00	$ 18.00
Percentage of exercise price of public warrants is adjusted higher than the market value of newly issued price	115.00%
Percentage of redemption triggered price is adjusted higher than the market value of newly issued price	180.00%
Class A Ordinary Shares [Member] \| Minimum [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 12.00	$ 12.00
Percentage of aggregate gross proceeds of issuance available for funding of business combination	60.00%	60.00%
Class A Ordinary Shares [Member] \| Maximum [Member]
Warrants [Abstract]
Additional shares issued with the closing of business combination (in dollars per share)	$ 9.20	$ 9.20

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Q3) (Details) - USD ($)		3 Months Ended	4 Months Ended	7 Months Ended	9 Months Ended
	Aug. 12, 2019	Sep. 30, 2019	Sep. 30, 2019	Dec. 31, 2019	Sep. 30, 2020
Proceeds from Issuance of Equity [Abstract]
Share price (in dollars per share)	$ 1.00
Warrants issued (in shares)	7,000,000
Gross proceeds from issuance of warrants	$ 7,000,000
Transaction costs	14,413,362
Underwriting fees	5,000,000			$ 5,000,000
Deferred underwriting fees	8,750,000			8,750,000
Other offering costs	663,362			663,362
Cash				894,589	$ 623,644
Investment of cash in Trust Account	$ 250,000,000		$ 250,000,000	250,000,000	0
Amount of interest to pay dissolution expenses				$ 100,000	$ 100,000
Private Placement Warrants [Member]
Proceeds from Issuance of Equity [Abstract]
Share price (in dollars per share)	$ 1.00
Warrants issued (in shares)	7,000,000	7,000,000		7,000,000
Gross proceeds from issuance of warrants	$ 7,000,000
Initial Public Offering [Member]
Proceeds from Issuance of Equity [Abstract]
Units issued (in shares)	25,000,000			25,000,000
Share price (in dollars per share)	$ 10.00			$ 10.00
Redemption price (in dollars per share)	$ 10.00
Initial Public Offering [Member] \| Public Shares [Member]
Proceeds from Issuance of Equity [Abstract]
Units issued (in shares)	25,000,000
Share price (in dollars per share)	$ 10.00
Gross proceeds from initial public offering	$ 250,000,000
Redemption price (in dollars per share)	$ 10.00

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Loss Per Ordinary Share (Q3) (Details) - USD ($)

1 Months Ended

3 Months Ended

4 Months Ended

7 Months Ended

9 Months Ended

Jun. 30, 2019

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2019

Dec. 31, 2019

Sep. 30, 2020

Cash and Cash Equivalents [Abstract]

Cash equivalents

$ 0

Reconciliation of Net Loss per Ordinary Share [Abstract]

Net (loss) income

$ (5,000)

(113,960)

$ (161,809)

$ 1,627,107

$ 553,123

$ 548,123

1,618,159

1,351,338

Less: Income attributable to ordinary shares subject to possible redemption

(42,655)

(652,406)

(1,827,973)

(2,074,028)

Adjusted net loss

$ (156,615)

$ (99,283)

$ (104,283)

$ (209,814)

$ (722,690)

Weighted average shares outstanding, basic and diluted (in shares)

^[1]

7,566,134

6,910,082

6,792,210

7,111,079

7,538,169

Basic and diluted net loss per ordinary share (in dollars per share)

^[2]

$ (0.02)

$ (0.01)

$ (0.02)

$ (0.03)

$ (0.10)

Class A Ordinary Shares [Member]

Net Loss per Ordinary Share [Abstract]

Shares excluded in calculation of diluted loss per share (in shares)

19,500,000

[1]	Excludes an aggregate of 23,668,455 and 23,750,733 shares subject to possible redemption at September 30, 2020 and 2019, respectively.
[2]	Net loss per ordinary share - basic and diluted excludes income attributable to ordinary shares subject to possible redemption of $42,655 and $2,074,028 for the three and nine months ended September 30, 2020, respectively, and $652,406 for the three months ended September 30, 2019 and for the period from June 7, 2019 (inception) through September 30, 2019, respectively (see Note 2).

RELATED PARTY TRANSACTIONS, Founder Shares (Q3) (Details)		1 Months Ended	3 Months Ended	7 Months Ended	9 Months Ended
	Sep. 26, 2019 shares	Jun. 30, 2019 USD ($) shares	Sep. 30, 2019 shares	Dec. 31, 2019 USD ($) $ / shares shares	Sep. 30, 2020 $ / shares shares
Related Party Transactions [Abstract]
Proceeds from issuance of common stock to Sponsor \| $				$ 245,000,000
Number of trading days				20 days	20 days
Trading day threshold period				30 days	30 days
Class A Ordinary Shares [Member]
Related Party Transactions [Abstract]
Number of shares outstanding (in shares)				1,259,819	1,331,545
Share price threshold to transfer, assign or sell shares (in dollars per share) \| $ / shares				$ 18.00	$ 18.00
Class A Ordinary Shares [Member] \| Minimum [Member]
Related Party Transactions [Abstract]
Share price threshold to transfer, assign or sell shares (in dollars per share) \| $ / shares				$ 12.00	$ 12.00
Threshold period after initial business combination				150 days	150 days
Class B Ordinary Shares [Member]
Related Party Transactions [Abstract]
Forfeiture of ordinary shares (in shares)			937,500	937,500
Number of shares outstanding (in shares)				6,250,000	6,250,000
Sponsor [Member] \| Class A Ordinary Shares [Member]
Related Party Transactions [Abstract]
Number of trading days				20 days	20 days
Trading day threshold period				30 days	30 days
Sponsor [Member] \| Class B Ordinary Shares [Member]
Related Party Transactions [Abstract]
Shares issued (in shares)		7,187,500
Proceeds from issuance of common stock to Sponsor \| $		$ 25,000
Stock conversion ratio		1
Percentage of shares held by Founder after Initial Public Offering		20.00%		20.00%
Forfeiture of ordinary shares (in shares)	937,500
Number of shares outstanding (in shares)				6,250,000	6,250,000
Sponsor [Member] \| Class B Ordinary Shares [Member] \| Maximum [Member]
Related Party Transactions [Abstract]
Number of shares subject to forfeiture (in shares)			937,500	937,500

SHAREHOLDERS' EQUITY, Ordinary Shares (Q3) (Details)	7 Months Ended	9 Months Ended
SHAREHOLDERS' EQUITY, Ordinary Shares (Q3) (Details)	Dec. 31, 2019 Vote $ / shares shares	Sep. 30, 2020 Vote $ / shares shares	Sep. 30, 2019 shares
Stockholders' Equity [Abstract]
Ordinary shares subject to possible redemption (in shares)	23,740,181	23,668,455	23,750,733
Conversion of stock at the time of an initial business combination (in shares)	1	1
Stock conversion percentage threshold	20.00%	20.00%
Class A Ordinary Shares [Member]
Stockholders' Equity [Abstract]
Ordinary shares, shares authorized (in shares)	200,000,000	200,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Votes per share \| Vote	1	1
Ordinary shares, shares issued (in shares)	1,259,819	1,331,545
Ordinary shares, shares outstanding (in shares)	1,259,819	1,331,545
Ordinary shares subject to possible redemption (in shares)	23,740,181	23,668,455
Class B Ordinary Shares [Member]
Stockholders' Equity [Abstract]
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Votes per share \| Vote	1	1
Ordinary shares, shares issued (in shares)	6,250,000	6,250,000
Ordinary shares, shares outstanding (in shares)	6,250,000	6,250,000

SHAREHOLDERS' EQUITY, Warrants (Q3) (Details) - $ / shares	7 Months Ended	9 Months Ended
	Dec. 31, 2019	Sep. 30, 2020
Warrants [Abstract]
Period to exercise warrants after business combination	30 days	30 days
Period to exercise warrants after public offerings	12 months	12 months
Expiration period of warrants	5 years	5 years
Number of days to file registration statement	15 days	15 days
Period for registration statement to become effective	60 days	60 days
Warrant redemption price (in dollars per share)	$ 0.01	$ 0.01
Notice period to redeem warrants	30 days	30 days
Number of trading days	20 days	20 days
Trading day threshold period	30 days	30 days
Limitation period to transfer, assign or sell warrants	30 days	30 days
Class A Ordinary Shares [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 18.00	$ 18.00
Percentage of exercise price of public warrants is adjusted higher than the market value of newly issued price		115.00%
Percentage of redemption triggered price is adjusted higher than the market value of newly issued price		180.00%
Class A Ordinary Shares [Member] \| Minimum [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 12.00	$ 12.00
Percentage of aggregate gross proceeds of issuance available for funding of business combination	60.00%	60.00%
Class A Ordinary Shares [Member] \| Maximum [Member]
Warrants [Abstract]
Additional shares issued with the closing of business combination (in dollars per share)	$ 9.20	$ 9.20

INITIAL PUBLIC OFFERING (FY)	9 Months Ended	12 Months Ended
INITIAL PUBLIC OFFERING (FY)	Sep. 30, 2020	Dec. 31, 2019
INITIAL PUBLIC OFFERING [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7).	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7).

PRIVATE PLACEMENT (FY)	9 Months Ended	12 Months Ended
PRIVATE PLACEMENT (FY)	Sep. 30, 2020	Dec. 31, 2019
PRIVATE PLACEMENT [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,000,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,000,000. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. Each Private Placement Warrant is exercisable for one Class A Share at a price of $11.50 per share, subject to adjustment (see Note 7). If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,000,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,000,000. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. Each Private Placement Warrant is exercisable for one Class A Share at a price of $11.50 per share, subject to adjustment (see Note 7). If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

COMMITMENTS (FY)	9 Months Ended	12 Months Ended
COMMITMENTS (FY)	Sep. 30, 2020	Dec. 31, 2019
COMMITMENTS [Abstract]
COMMITMENTS	NOTE 6. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on August 7, 2019, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,000,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,750,000 in the aggregate, which will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.	NOTE 6. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on August 7, 2019, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,000,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,750,000 in the aggregate, which will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

SUBSEQUENT EVENTS (FY)	9 Months Ended	12 Months Ended
SUBSEQUENT EVENTS (FY)	Sep. 30, 2020	Dec. 31, 2019
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

INITIAL PUBLIC OFFERING (Q3)	9 Months Ended	12 Months Ended
INITIAL PUBLIC OFFERING (Q3)	Sep. 30, 2020	Dec. 31, 2019
INITIAL PUBLIC OFFERING [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7).	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7).

STATEMENTS OF OPERATIONS (FY) (Parenthetical) - USD ($)	3 Months Ended		4 Months Ended	7 Months Ended	9 Months Ended
STATEMENTS OF OPERATIONS (FY) (Parenthetical) - USD ($)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2019	Dec. 31, 2019	Sep. 30, 2020
STATEMENT OF OPERATIONS [Abstract]
Ordinary shares subject to possible redemption (in shares)	23,668,455	23,750,733	23,750,733	23,740,181	23,668,455
Income attributable to ordinary shares subject to possible redemption	$ 42,655	$ 652,406	$ 652,406	$ 1,827,973	$ 2,074,028

PRIVATE PLACEMENT (Q3)	9 Months Ended	12 Months Ended
PRIVATE PLACEMENT (Q3)	Sep. 30, 2020	Dec. 31, 2019
PRIVATE PLACEMENT [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,000,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,000,000. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. Each Private Placement Warrant is exercisable for one Class A Share at a price of $11.50 per share, subject to adjustment (see Note 7). If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,000,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,000,000. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. Each Private Placement Warrant is exercisable for one Class A Share at a price of $11.50 per share, subject to adjustment (see Note 7). If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

COMMITMENTS (Q3)	9 Months Ended	12 Months Ended
COMMITMENTS (Q3)	Sep. 30, 2020	Dec. 31, 2019
COMMITMENTS [Abstract]
COMMITMENTS	NOTE 6. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on August 7, 2019, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,000,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,750,000 in the aggregate, which will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.	NOTE 6. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on August 7, 2019, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,000,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,750,000 in the aggregate, which will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

SUBSEQUENT EVENTS (Q3)	9 Months Ended	12 Months Ended
SUBSEQUENT EVENTS (Q3)	Sep. 30, 2020	Dec. 31, 2019
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

INITIAL PUBLIC OFFERING (FY) (Details) - $ / shares		7 Months Ended
INITIAL PUBLIC OFFERING (FY) (Details) - $ / shares	Aug. 12, 2019	Dec. 31, 2019	Sep. 30, 2020
Initial Public Offering [Abstract]
Unit price (in dollars per share)	$ 1.00
Initial Public Offering [Member]
Initial Public Offering [Abstract]
Units issued (in shares)	25,000,000	25,000,000
Unit price (in dollars per share)	$ 10.00	$ 10.00
Initial Public Offering [Member] \| Public Warrant [Member]
Initial Public Offering [Abstract]
Number of ordinary shares included in each unit (in shares)		0.5
Exercise price of warrant (in dollars per share)		$ 11.50	$ 11.50
Initial Public Offering [Member] \| Class A Ordinary Shares [Member]
Initial Public Offering [Abstract]
Number of ordinary shares included in each unit (in shares)		1	1
Number of ordinary shares called by each warrant (in shares)		1	1

PRIVATE PLACEMENT (FY) (Details) - USD ($)		3 Months Ended	7 Months Ended
PRIVATE PLACEMENT (FY) (Details) - USD ($)	Aug. 12, 2019	Sep. 30, 2019	Dec. 31, 2019	Sep. 30, 2020
Private Placement [Abstract]
Warrants issued (in shares)	7,000,000
Share price (in dollars per share)	$ 1.00
Proceeds from private placement of warrants	$ 7,000,000
Private Placement Warrants [Member]
Private Placement [Abstract]
Warrants issued (in shares)	7,000,000	7,000,000	7,000,000
Share price (in dollars per share)	$ 1.00
Proceeds from private placement of warrants	$ 7,000,000
Private Placement Warrants [Member] \| Class A Ordinary Shares [Member]
Private Placement [Abstract]
Number of ordinary shares called by each warrant (in shares)			1	1
Exercise price of warrant (in dollars per share)			$ 11.50	$ 11.50

RELATED PARTY TRANSACTIONS, Promissory Note (FY) (Details)	Jun. 10, 2019 USD ($)
Sponsor [Member] \| Promissory Note [Member]
Related Party Transactions [Abstract]
Aggregate principal amount of note	$ 237,470

RELATED PARTY TRANSACTIONS, Administrative Services Agreement (FY) (Details) - Sponsor [Member] - Administrative Services Agreement [Member] - USD ($)		3 Months Ended	7 Months Ended	9 Months Ended
	Aug. 07, 2019	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2020
Related Party Transactions [Abstract]
Fees incurred		$ 60,000	$ 92,903	$ 180,000
Accrued Expenses [Member]
Related Party Transactions [Abstract]
Fees payable		$ 219,879	$ 82,228	$ 219,879
Maximum [Member]
Related Party Transactions [Abstract]
Monthly related party fee	$ 20,000

COMMITMENTS (FY) (Details) - USD ($)		7 Months Ended
COMMITMENTS (FY) (Details) - USD ($)	Aug. 12, 2019	Dec. 31, 2019
COMMITMENTS [Abstract]
Cash underwriting discount (in dollars per share)	$ 0.20	$ 0.20
Underwriting fees	$ 5,000,000	$ 5,000,000
Deferred underwriting discount (in dollars per share)	$ 0.35	$ 0.35
Deferred underwriting fees	$ 8,750,000	$ 8,750,000

FAIR VALUE MEASUREMENTS (FY) (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Recurring [Member] \| Level 1 [Member]
Fair Value Measurements [Abstract]
Marketable securities held in Trust Account	$ 254,115,791	$ 251,924,993

INITIAL PUBLIC OFFERING (Q3) (Details) - $ / shares		7 Months Ended	9 Months Ended
INITIAL PUBLIC OFFERING (Q3) (Details) - $ / shares	Aug. 12, 2019	Dec. 31, 2019	Sep. 30, 2020
Initial Public Offering [Abstract]
Unit price (in dollars per share)	$ 1.00
Initial Public Offering [Member]
Initial Public Offering [Abstract]
Units issued (in shares)	25,000,000	25,000,000
Unit price (in dollars per share)	$ 10.00	$ 10.00
Initial Public Offering [Member] \| Public Warrant [Member]
Initial Public Offering [Abstract]
Number of ordinary shares included in each unit (in shares)		0.5
Number of warrants included in each unit (in shares)			0.5
Exercise price of warrant (in dollars per share)		$ 11.50	$ 11.50
Initial Public Offering [Member] \| Class A Ordinary Shares [Member]
Initial Public Offering [Abstract]
Number of ordinary shares included in each unit (in shares)		1	1
Number of ordinary shares called by each warrant (in shares)		1	1

PRIVATE PLACEMENT (Q3) (Details) - USD ($)		3 Months Ended	7 Months Ended
PRIVATE PLACEMENT (Q3) (Details) - USD ($)	Aug. 12, 2019	Sep. 30, 2019	Dec. 31, 2019	Sep. 30, 2020
Private Placement [Abstract]
Warrants issued (in shares)	7,000,000
Share price (in dollars per share)	$ 1.00
Proceeds from private placement of warrants	$ 7,000,000
Private Placement Warrants [Member]
Private Placement [Abstract]
Warrants issued (in shares)	7,000,000	7,000,000	7,000,000
Share price (in dollars per share)	$ 1.00
Proceeds from private placement of warrants	$ 7,000,000
Private Placement Warrants [Member] \| Class A Ordinary Shares [Member]
Private Placement [Abstract]
Number of ordinary shares called by each warrant (in shares)			1	1
Exercise price of warrant (in dollars per share)			$ 11.50	$ 11.50

COMMITMENTS (Q3) (Details) - USD ($)		7 Months Ended
COMMITMENTS (Q3) (Details) - USD ($)	Aug. 12, 2019	Dec. 31, 2019
COMMITMENTS [Abstract]
Cash underwriting discount (in dollars per share)	$ 0.20	$ 0.20
Underwriting fees	$ 5,000,000	$ 5,000,000
Deferred underwriting discount (in dollars per share)	$ 0.35	$ 0.35
Deferred underwriting fees	$ 8,750,000	$ 8,750,000